PARSIPPANY, N.J., May 24, 2017 -- Pinnacle Foods Inc. (NYSE:PF) announced today that its Board of Directors has declared a quarterly cash dividend of $0.285 per share, payable on July 7, 2017 to all common stockholders of record at the close of business on June 6, 2017.
Pinnacle Foods Contact
Maria Sceppaguercio
Sr. Vice President, Investor Relations
973-541-8629
About Pinnacle Foods Inc.
Pinnacle Foods Inc. (NYSE:PF) is a leading manufacturer, marketer and distributor of high-quality branded food products with a mission of unleashing brand potential. With annual sales in excess of $3 billion, our portfolio includes well-known brands competing in frozen, refrigerated and shelf-stable formats, such as Birds Eye, Birds Eye Voila!, Duncan Hines, Earth Balance, EVOL, Gardein, Glutino, Hungry-Man, Log Cabin, Udi’s, Vlasic, and Wish-Bone, along with many others. The company is headquartered in Parsippany, NJ and has nearly 5,000 employees across the U.S. and Canada. For more information, please visit www.pinnaclefoods.com.


Puma’s Historic Rivalry With Adidas Enters a New Era as Anta Deal Signals Turnaround Push
Toyota Retains Global Auto Sales Crown in 2025 With Record 11.3 Million Vehicles Sold
NVIDIA, Microsoft, and Amazon Eye Massive OpenAI Investment Amid $100B Funding Push
Samsung Electronics Posts Record Q4 2025 Profit as AI Chip Demand Soars
Climate Adaptation at Home: How Irrigreen Makes Conservation Effortless
Volkswagen CEO Oliver Blume Faces Crucial Year as Investors Demand Turnaround Results
Apple Faces Margin Pressure as Memory Chip Prices Surge Amid AI Boom
Google Halts UK YouTube TV Measurement Service After Legal Action
Apple Earnings Beat Expectations as iPhone Sales Surge to Four-Year High
Sandisk Stock Soars After Blowout Earnings and AI-Driven Outlook
Elon Musk’s SpaceX Explores Merger Options With Tesla or xAI, Reports Say
ASML’s EUV Lithography Machines Power Europe’s Most Valuable Tech Company
The Maire - EuroChem Case: Three Lessons for Global Business
Amazon Stock Dips as Reports Link Company to Potential $50B OpenAI Investment
Pentagon and Anthropic Clash Over AI Safeguards in National Security Use
CSPC Pharma and AstraZeneca Forge Multibillion-Dollar Partnership to Develop Long-Acting Peptide Drugs 



